Arbutus Biopharma Corp
|Market Cap (Intraday)||398.62M|
|2yr Forward PE||N/A|
Arbutus Biopharma Corp Stock, NASDAQ:ABUS
Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.